Status: current, Defined. Date: 30-Apr 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1581601000168114 | Bupradone 2/0.5 (buprenorphine 2 mg + naloxone 500 microgram) sublingual tablet, 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1581611000168112 | Bupradone 2/0.5 sublingual tablet, 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bupradone 2/0.5 sublingual tablet, 28, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Bupradone 2/0.5 sublingual tablet, 28, blister pack | Is a | Bupradone 2/0.5 sublingual tablet, 28 | true | Inferred relationship | Some | ||
| Bupradone 2/0.5 sublingual tablet, 28, blister pack | has TPUU | Bupradone 2/0.5 sublingual tablet | true | Inferred relationship | Some | 1 | |
| Bupradone 2/0.5 sublingual tablet, 28, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Bupradone 2/0.5 sublingual tablet, 28, blister pack | has TP | Bupradone 2/0.5 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Schedule 8 medications reference set
Containered trade product pack reference set
FHIR